Midjourney Medical Announces 60-Second Full-Body Ultrasound CT Scanner and "Midjourney Spa" Experience

Midjourney Medical has announced the Midjourney Spa, a consumer-facing whole-body scan experience built around an Ultrasonic CT scanner it says can complete a full-body scan in 60 seconds, according to a blog post published on June 18, 2026.

The San Francisco-based company is developing what it describes as the world's first full-body ultrasound CT scanner — a modality that uses sound waves and a water medium rather than ionizing radiation or magnetic fields. The absence of both X-ray exposure and the high-field magnets required by MRI removes two of the most significant friction points in high-frequency or population-scale body imaging: cumulative radiation dose and the contraindications that make MRI inaccessible to patients with implanted metal devices, pacemakers, or severe claustrophobia.

Ultrasonic CT is not a new concept in research literature, but translating it into a clinically or commercially viable full-body platform has been a long-standing engineering challenge. Conventional diagnostic ultrasound is highly operator-dependent, limited in penetration depth for deep abdominal or thoracic structures, and produces images that are difficult to reconstruct into the volumetric datasets that radiologists and AI diagnostic tools expect. Midjourney Medical's pitch is that its approach resolves enough of those constraints to support a 60-second full-body acquisition — a throughput figure that, if it holds under clinical conditions, would be genuinely difficult to match with any existing modality.

The Midjourney Spa framing positions the scanner as a wellness or preventive health product rather than a diagnostic device, which carries its own regulatory logic. Consumer wellness devices operate under a materially different FDA oversight regime than cleared diagnostic imaging equipment, and how Midjourney Medical intends to navigate that boundary — and what clinical claims, if any, it will make about scan outputs — will be a defining question as the product moves toward deployment. The company has not, in publicly available materials, specified its regulatory pathway.

Midjourney Medical's careers page lists open roles across engineering and operations, signaling that the company is still in an active build phase rather than a commercialization ramp. That hiring posture is consistent with an early-stage hardware program: full-body ultrasound CT involves dense engineering problems in transducer array design, acoustic reconstruction algorithms, water-bath mechanics, and the real-time compute stack needed to turn raw acoustic data into interpretable volumetric imagery.

Worth flagging for engineers and clinicians reading this: the 60-second scan claim is the kind of number that warrants scrutiny before being treated as a production specification. Scan time in imaging is rarely a single figure — it interacts with resolution, field of view, patient motion tolerance, and reconstruction latency. Whether that 60 seconds refers to raw data acquisition, full volumetric reconstruction, or reviewed output is not yet clear from available public disclosures.

The broader competitive context is worth mapping. The preventive, high-throughput body scanning space has attracted significant investment in recent years, most visibly through companies like Prenuvo, which uses MRI for whole-body screening, and Ezra, which applies AI to MRI-derived datasets. Both face the same throughput ceiling that MRI physics imposes: a typical whole-body MRI scan takes 45 to 90 minutes. An ultrasound-based platform that can achieve comparable anatomical coverage in a fraction of that time — without radiation or magnet infrastructure — would have a structurally different cost and deployment profile. The capital cost of MRI suites and their siting requirements (shielded rooms, cryogen supply chains for superconducting magnets) are non-trivial barriers to scaling preventive imaging as a consumer service.

None of that changes the fact that Midjourney Medical is, by its own description, still building the device. The careers listings, the absence of cleared regulatory status in public materials, and the spa-experience framing all point to a company at a pre-commercial stage. The announcement is a signal of intent and a recruiting instrument as much as a product launch.

The name alone will draw attention. Midjourney is one of the most recognized brands in generative AI image synthesis, and Midjourney Medical appears to be a distinct entity working in an entirely different domain. Whether there is any corporate relationship between the two, or whether the shared name is coincidental, is not established by currently available sources.